Intrinsic Value of S&P & Nasdaq Contact Us

Aldeyra Therapeutics, Inc. ALDX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
60/100
3/6 Pass
SharesGrow Intrinsic Value
$414,729,000.00
+23169217777.1%
Analyst Price Target
$7.00
+291.1%

Stock Statistics — ALDX

Aldeyra Therapeutics, Inc. (ALDX) has a market capitalization of $107.73M and trades at $1.79. The 52-week range is 1.07-6.175.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.2, Earnings Per Share (EPS) of $-0.56.

The stock has a beta of 1.33, operates in the Healthcare sector.

Trading Data
Current Price$1.79
52-Week Range1.07-6.175
Volume2.02M
Avg Volume (30D)3.05M
Market Cap$107.73M
Beta (1Y)1.33
Company
IPO Date2014-05-02
Employees9
CEOTodd C. Brady
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS01438T1060
CUSIP01438T106
Income (Latest Year)
Gross Profit$-251.99K
EBITDA$-31.69M
Operating Income$-35.27M
Net Income$-33.85M
EPS$-0.56
EPS Diluted$-0.56
Shares Outstanding$60.06M
Balance Sheet (Latest Year)
Total Assets$72.06M
Current Assets$71.78M
Cash & ST Investments$70.04M
Total Liabilities$27.81M
Total Debt$15.53M
Net Debt$-54.51M
Total Equity$44.25M
Debt / Equity0.35
Valuation Ratios
P/E Ratio-3.2
P/B Ratio2.43
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message